ODG
TEVA icon

O'Dell Group’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

O'Dell Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25
Closed – – 578
2021
Q4 		$0 Hold
25
– – ﹤0.01% 545
2021
Q3 		$0 Buy
+25
New +$234 ﹤0.01% 504

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

O'Dell Group's TEVA Position: Q1 2022 in Review

O'Dell Group sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2022, closing a stake of 25 shares.

O'Dell Group first reported a position in TEVA in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q4 2021. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

  • O'Dell Group reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2022 after selling out during the quarter.
  • O'Dell Group sold 25 Teva Pharmaceutical Industries Limited shares in Q1 2022.
  • O'Dell Group first reported a position in Teva Pharmaceutical Industries Limited in Q3 2021 and held it in 2 quarters.
  • O'Dell Group's Teva Pharmaceutical Industries Limited position peaked at $0 in Q4 2021.
  • 438 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2022.

Based on O'Dell Group's 13F filing for Q1 2022, filed 5 May 2022.